Daiwa Securities Group’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.49M | Sell |
23,362
-16,067
| -41% | -$1.95M | ﹤0.01% | 652 |
|
|
2026
Q1 | $6.45M | Buy |
39,429
+1,178
| +3% | +$181K | 0.02% | 407 |
|
|
2025
Q4 | $6.66M | Buy |
38,251
+34,648
| +962% | +$6.32M | 0.02% | 393 |
|
|
2025
Q3 | $519K | Buy |
3,603
+2,968
| +467% | +$364K | ﹤0.01% | 861 |
|
|
2025
Q2 | $64K | Buy |
635
+30
| +5% | +$2.29K | ﹤0.01% | 1038 |
|
|
2025
Q1 | $46K | Buy |
605
+15
| +3% | +$1.15K | ﹤0.01% | 1027 |
|
|
2024
Q4 | $41K | Sell |
590
-45
| -7% | -$3.24K | ﹤0.01% | 1069 |
|
|
2024
Q3 | $46K | Buy |
635
+50
| +9% | +$3.69K | ﹤0.01% | 1069 |
|
|
2024
Q2 | $39K | Buy |
585
+40
| +7% | +$1.55K | ﹤0.01% | 1112 |
|
|
2024
Q1 | $15K | Hold |
545
| – | – | ﹤0.01% | 1147 |
|
|
2023
Q4 | $17K | Hold |
545
| – | – | ﹤0.01% | 1136 |
|
|
2023
Q3 | $14K | Hold |
545
| – | – | ﹤0.01% | 1113 |
|
|
2023
Q2 | $11K | Hold |
545
| – | – | ﹤0.01% | 1135 |
|
|
2023
Q1 | $9K | Hold |
545
| – | – | ﹤0.01% | 1115 |
|
|
2022
Q4 | $11K | Buy |
545
+100
| +22% | +$1.93K | ﹤0.01% | 1110 |
|
|
2022
Q3 | $10K | Hold |
445
| – | – | ﹤0.01% | 1126 |
|
|
2022
Q2 | $9K | Buy |
445
+100
| +29% | +$2.1K | ﹤0.01% | 1145 |
|
|
2022
Q1 | $8K | Hold |
345
| – | – | ﹤0.01% | 1149 |
|
|
2021
Q4 | $9K | Sell |
345
-50
| -13% | -$1.43K | ﹤0.01% | 1156 |
|
|
2021
Q3 | $11K | Buy |
395
+191
| +94% | +$5.01K | ﹤0.01% | 1128 |
|
|
2021
Q2 | $6K | Hold |
204
| – | – | ﹤0.01% | 1063 |
|
|
2021
Q1 | $7K | Buy |
204
+12
| +6% | +$459 | ﹤0.01% | 1058 |
|
|
2020
Q4 | $6K | Sell |
192
-384
| -67% | -$14K | ﹤0.01% | 1047 |
|
|
2020
Q3 | $19K | Buy |
576
+72
| +14% | +$2.07K | ﹤0.01% | 997 |
|
|
2020
Q2 | $8K | Hold |
504
| – | – | ﹤0.01% | 1081 |
|
|
2020
Q1 | $8K | Hold |
504
| – | – | ﹤0.01% | 1073 |
|
|
2019
Q4 | $12K | Sell |
504
-45
| -8% | -$915 | ﹤0.01% | 1044 |
|
|
2019
Q3 | $10K | Hold |
549
| – | – | ﹤0.01% | 1032 |
|
|
2019
Q2 | $14K | Buy |
549
+56
| +11% | +$1.56K | ﹤0.01% | 1034 |
|
|
2019
Q1 | $14K | Buy |
493
+70
| +17% | +$1.81K | ﹤0.01% | 1011 |
|
|
2018
Q4 | $6K | Hold |
423
| – | – | ﹤0.01% | 1041 |
|
|
2018
Q3 | $9K | Hold |
423
| – | – | ﹤0.01% | 1048 |
|
|
2018
Q2 | $10K | Hold |
423
| – | – | ﹤0.01% | 1051 |
|
|
2018
Q1 | $10K | Buy |
+423
| New | +$11.1K | ﹤0.01% | 1029 |
|
Other funds holding INSM
BBA
DGM
OAG
Daiwa Securities Group's INSM Position: Q2 2026 in Review
Daiwa Securities Group reduced its Insmed (INSM) stake by 41% in Q2 2026, selling an estimated $1.95M and leaving 23,362 shares worth $2.49M. The position accounts for ﹤0.01% of the portfolio, ranked #652.
Daiwa Securities Group first reported a position in INSM in Q1 2018 and has held it in 34 quarters since. The position peaked at $6.66M in Q4 2025. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.
- Daiwa Securities Group held 23,362 shares of Insmed worth $2.49M as of Q2 2026.
- Daiwa Securities Group sold 16,067 Insmed shares in Q2 2026, an estimated $1.95M.
- Insmed made up ﹤0.01% of Daiwa Securities Group's portfolio in Q2 2026, its #652 holding.
- Daiwa Securities Group first reported a position in Insmed in Q1 2018 and has held it in 34 quarters since.
- Daiwa Securities Group's Insmed position peaked at $6.66M in Q4 2025.
- 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.
Based on Daiwa Securities Group's 13F filing for Q2 2026, filed 31 Jul 2026.